drugset / Trial / NCT00310609

Magnevist® Injection Enhanced MRA Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Aortic Arch and Cerebral Branches

NCT00310609

Phase 3 Completed 123 enrolled Bayer
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to look at the safety (what are the side effects) and efficacy (how well does it work) of Magnevist (the study drug) used for MRI of the aortic arch and cerebral branches. The results will be compared to the results of MRI taken without Magnevist, and with the results of your X-ray angiography.

Timeline

Start
2003-12
Primary completion
Completion
2004-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Gadopentetate dimeglumine Diagnostic / imaging agent 0.1 unknown Intravenous